GLYR1
Basic information
Region (hg38): 16:4803202-4847288
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (9 variants)
- GLYR1-related condition (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GLYR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 11 | 11 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 11 | 0 | 0 |
Variants in GLYR1
This is a list of pathogenic ClinVar variants found in the GLYR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-4811187-C-A | not specified | Uncertain significance (Jan 25, 2024) | ||
16-4811649-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
16-4812234-C-A | not specified | Uncertain significance (Dec 11, 2023) | ||
16-4814559-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
16-4814563-C-A | not specified | Uncertain significance (Oct 26, 2022) | ||
16-4821555-A-G | not specified | Uncertain significance (Jan 04, 2024) | ||
16-4821576-T-C | not specified | Uncertain significance (May 11, 2022) | ||
16-4822889-T-A | not specified | Uncertain significance (Feb 13, 2024) | ||
16-4822918-G-A | not specified | Uncertain significance (Jun 01, 2022) | ||
16-4823829-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
16-4823849-G-A | GLYR1-related disorder | Uncertain significance (Mar 09, 2018) | ||
16-4823850-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
16-4823861-C-A | GLYR1-related disorder | Uncertain significance (Mar 09, 2018) | ||
16-4823862-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
16-4823885-C-G | not specified | Uncertain significance (Dec 19, 2023) | ||
16-4832037-A-G | not specified | Uncertain significance (Oct 14, 2023) | ||
16-4832094-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
16-4832098-T-C | not specified | Uncertain significance (Dec 15, 2022) | ||
16-4832126-G-T | not specified | Uncertain significance (May 18, 2022) | ||
16-4832136-C-T | not specified | Uncertain significance (Jul 21, 2021) | ||
16-4832176-T-A | not specified | Uncertain significance (Jun 29, 2022) | ||
16-4832823-G-A | not specified | Uncertain significance (Dec 22, 2023) | ||
16-4832896-C-T | not specified | Uncertain significance (Feb 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GLYR1 | protein_coding | protein_coding | ENST00000321919 | 16 | 44140 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000274 | 125733 | 0 | 14 | 125747 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.34 | 215 | 336 | 0.640 | 0.0000199 | 3627 |
Missense in Polyphen | 20 | 68.911 | 0.29023 | 769 | ||
Synonymous | -3.87 | 193 | 136 | 1.42 | 0.00000901 | 1068 |
Loss of Function | 4.94 | 2 | 32.3 | 0.0619 | 0.00000168 | 373 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000911 | 0.0000907 |
Ashkenazi Jewish | 0.0000999 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000937 | 0.0000924 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Putative oxidoreductase that is recruited on chromatin and promotes KDM1B demethylase activity (PubMed:23260659). Recognizes and binds trimethylated 'Lys-36' of histone H3 (H3K36me3) (PubMed:20850016). Regulates p38 MAP kinase activity by mediating stress activation of p38alpha/MAPK14 and specifically regulating MAPK14 signaling (PubMed:16352664). Indirectly promotes phosphorylation of MAPK14 and activation of ATF2 (PubMed:16352664). The phosphorylation of MAPK14 requires upstream activity of MAP2K4 and MAP2K6 (PubMed:16352664). {ECO:0000269|PubMed:16352664, ECO:0000269|PubMed:20850016, ECO:0000269|PubMed:23260659}.;
Intolerance Scores
- loftool
- 0.108
- rvis_EVS
- -0.89
- rvis_percentile_EVS
- 10.3
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.673
- ghis
- 0.680
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.471
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Glyr1
- Phenotype
Gene ontology
- Biological process
- oxidation-reduction process
- Cellular component
- nucleosome;nucleoplasm;Golgi apparatus;cytosol;nuclear speck
- Molecular function
- DNA binding;protein binding;oxidoreductase activity;methylated histone binding;histone binding;NADP binding;NAD binding